Latest Ulcerative colitis Stories
LONDON, January 22, 2015 /PRNewswire/ -- Report Details Treating Crohn's disease and ulcerative colitis - how to find R&D trends, opportunities and revenue
NEW YORK, Jan.
- Trial results show novel S1P1 modulator produced strong, dose-dependent lymphocyte lowering - SAN DIEGO, Jan. 7, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
NEW YORK, Dec.
PTG-100, a Novel Peptide as an 'Oral Targeted Therapy' for Inflammatory Bowel Diseases MILPITAS, Calif., Dec.
CCFA highlights the now 1.6 million Americans with these autoimmune diseases with new social media campaign during Crohn's & Colitis Awareness Week December 1-7, 2014 NEW YORK, Dec.
MIAMI LAKES, Fla., Nov.
Tavish & Trevor Margers highlight 450 runners and walkers representing Team Challenge at the sixth annual Rock 'n' Roll Las Vegas Marathon & 1/2 Marathon. NEW YORK, Nov.
FREIBURG and HEIDELBERG, Germany, October 29, 2014 /PRNewswire/ -- Positive FDA feedback on the protocol for the US Phase III trial with LT-02,
- To fire mitraille at.